Global Anti-Infective Drugs Market Report 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Anti-Infective Drugs Global Market Report 2019" report has been added to ResearchAndMarkets.com's offering.

Global Anti-Infective Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.

Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Infective Drugs market global report answers all these questions and many more.

The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.

North America was the largest region in the global anti-infective drugs market, accounting for 44% of the market in 2018. Western Europe was the second largest region accounting for 23% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.

Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion's lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir.

Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting 'LpxC' for the treatment of bacterial infections.

Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157

Key Topics Covered:

1. Executive Summary

2. Report Structure

3. Anti-Infective Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Anti-Infective Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Anti-Infective Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Anti-Infective Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Anti-Infective Drugs Market Trends And Strategies

8. Anti-Infective Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value ($ Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value ($ Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Anti-Infective Drugs Market Regional Analysis

9.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)

9.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region

9.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region

10. Anti-Infective Drugs Market Segmentation

10.1. Global Anti-Infective Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)

10.1.1. Antibiotics

10.1.2. Antivirals

10.1.3. Antifungals

10.1.4. Others (Anthelminthic, Antiprotozoal)

11. Anti-Infective Drugs Market Metrics

11.1. Anti-Infective Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global

11.2. Per Capita Average Anti-Infective Drugs Market Expenditure, 2014 - 2022, Global

Companies Mentioned

  • Gilead
  • Merck & Co
  • GlaxosmithKline
  • Bristol-Myers Squibb Company
  • Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/r/snmxul

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs